Stay updated on Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The Study Details page updated its revision label from v3.6.3 to v3.6.4, representing a small page patch rather than new or altered study information.
    Difference
    0.0%
    Check dated 2026-07-27T05:43:18.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.3, indicating a small publishing update to the page's version rather than changes to the study data or displayed content.
    Difference
    0.0%
    Check dated 2026-07-05T13:33:49.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The study details page revision tag was updated from v3.6.0 to v3.6.2, signaling a small maintenance update to the page’s underlying system.
    Difference
    0.0%
    Check dated 2026-06-28T08:16:15.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The study record now indicates it is not actively enrolling participants and adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study); the revision tag was updated to v3.6.0 and the Intervention/Treatment heading formatting was adjusted.
    Difference
    0.4%
    Check dated 2026-06-14T04:48:54.000Z thumbnail image
  8. Check
    59 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.4 to v3.5.5, signaling a minor maintenance update to the page.
    Difference
    0.1%
    Check dated 2026-06-07T00:19:22.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page received a minor version update (revision to a newer build). This appears to be software maintenance with no visible changes to the study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-05-16T09:24:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High-Grade Neuroendocrine Carcinomas Clinical Trial page.